Cerner provides research solutions and services to support clinical sites and academic institutions. We bring a deep understanding of clinical systems, workflows and health data, as well as extensive experience in pharmaceutical, outcomes and health economic research. Through medical and economic analyses, researchers gain insights into the viability, safety, and efficacy of new and existing therapies. Principal investigators and research coordinators can use the Cerner EHR to facilitate and enhance their research activities.
“The Cerner team's work has proved that they have become much more than just technology suppliers to the Trust and now must be considered partners in delivering wide-reaching and significant organisational change across the hospital.”
— Emma Goddard, director of service development, Milton Keynes Hospital NHS Foundation Trust
Amanda Green, Cerner’s regional general manager for the Nordic region, talks to Eolas about how information technology can transform healthcare to improve patient outcomes.
Close to my heart is our ability to close the loop between discovering new things in research and implementing them in real world clinical practice. We have proven our abilities to do this with Sepsis and other predictive algorithms and have contributed our new learnings back into the peer-reviewed literature. Driving adoption of evidence based care and best practice is one of the key ways we help create a World Without Medical Error, which is our outrageous ambition here at Cerner.
Eolas magazine talks to Aiden Malone, senior director of European consulting for Cerner, about transforming healthcare and Cerner's journey in helping to apply technology to reduce deaths from sepsis.
Cerner supports research in many ways. We help clients with data for clinical research, we provide dedicated research solutions for data and running research programmes, we provide clinical research expertise, we develop predictive algorithms often in collaboration with our clients, we have partnerships with universities and fund research in them.
EHR systems are rich repositories for research on patients but also on workflows for better managing the process of healthcare. Our clients regularly use data from our platforms to support their research or the research of others.
In the USA, we have a service called HealthFacts where clients using Millennium® participate to share anonymous data for research purposes. HealthFacts contains over 42 million patient records and there have been over 300 publications using this data, and researchers in the UK can access data marts for research purposes. Data can be extracted in anonymous format for the UK market to support research.
Clients are researching new intelligence and predictive algorithms using this data, validating in real populations, publishing in the peer reviewed literature and making available to healthcare organisations at large.
Cerner’s PowerTrials solution works with Cerner Millennium EHR to help run and manage clinical trial protocols. Given that some 85 percent of trials are delayed due to accrual challenges, one key advantage is making use of the data to increase patient recruitment, with the solution matching research to patients and patients to research. Most healthcare professionals are unware of research at their institution, and the solution not only creates this awareness, but also safeguards patients through flagging and alerting that they are on a trial. Study protocols are run in the EHR alongside normal care but with the opportunity to separate costs for individual research funding streams.
Cerner is working with clients to pioneer how to improve the clinical utility of genomics.
Our first area of focus is in the operation of a modern, complex molecular laboratory. We built a cloud-based solution, Cerner Laboratory Sequence, to drive this complex workflow and integrate with all the devices in the lab, both physical and in silico. By leveraging our strength and history in the traditional laboratory workflow, Cerner Laboratory Sequence is the clinical informatics bridge between the traditional laboratory and the molecular laboratory for orders and results. It is currently live with several clients in the US and we are exploring expansion into global markets with a Cerner cloud footprint.
Beyond the molecular workflow, Cerner is working with our clients to define the correct roles and data needed in the EHR to support genomic-driven precision medicine. Examples of this client-driven work include incorporating the genetic councillor into a formal EHR workflow, pilot projected around capturing a structured phenotypes and family history via third-party tools, and NLP-based extraction of phenotype via chart search.
For our EHR-based work with our clients, we are heavily leveraging a standards-backed approach via SMART® on FHIR® and CDS Hooks. Through significant investments both in our client infrastructure and associate thought leadership, we are developing a clear path and plan for third-party interests, such as a genomic content provider for pharmacogenomics, to integrate into the Cerner family of solutions. While some of the FHIR services (such as sequence for genomics) are very nascent, Cerner believes that this pluggable-architecture approach provides a scalable foundation for precision medicine for our clients.
Beyond enabling the laboratory and clinical workflow, Cerner is also driving the connections between the traditionally separate worlds of clinical data and research data. Leveraging our track record in supporting clinical research and population health, we are working with our clients produce scalable, secure aggregation and visualisation of healthcare data across clinical and research venues.
Read how we are forming partnerships with academic institutions and supporting clinical research.
Aggregate and normalise data across the health and care economy to improve performance and outcomes.
We want to work with you to improve the value of your organisation.
Create the most relevant, timely and useful reports to help you understand the past, monitor the present and impact the future.